Literature DB >> 24153159

Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece.

Orthodoxia Mastrogianni1, Emma Gbandi, Amvrosios Orphanidis, Nikolaos Raikos, Evangelia Goutziomitrou, Efstratios M Kolibianakis, Basil C Tarlatzis, Antonis Goulas.   

Abstract

Cytochrome P450 2B6 (CYP2B6) is responsible for the initial biotransformation of profol, an extensively metabolized intravenous anesthetic. In this study we examined the effect of the apparently functional CYP2B6 c.516G>T polymorphism on the distribution of propofol concentrations, quantified by GC/MS analysis following a single bolus dose, in the blood of 44 Greek women undergoing oocyte retrieval. Univariate analysis using age, height, weight and smoking status as covariates, as well as the Mann-Whitney non-parametric test, revealed a strong trend of association of the T allele with high propofol concentrations determined in whole blood, shortly after a single bolus dose. Propofol concentrations which were higher than one standard deviation of the mean were almost invariably associated with carriage of the T allele.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24153159     DOI: 10.2133/dmpk.dmpk-13-nt-092

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  14 in total

1.  CYP2B6 Genotype Guided Dosing of Propofol Anesthesia in the Elderly based on Nonparametric Population Pharmacokinetic Modeling and Simulations.

Authors:  Andy R Eugene
Journal:  Int J Clin Pharmacol Toxicol       Date:  2017-01-03

2.  Fatal intoxication with antidepressants: a case with many culprits.

Authors:  Antonis Goulas; Nikolaos Raikos; Diamantis Krokos; Orthodoxia Mastrogianni; Amvrosios Orphanidis; Konstantinos Zisopoulos; Androniki Tsepa
Journal:  Forensic Sci Med Pathol       Date:  2018-02-27       Impact factor: 2.007

3.  Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability.

Authors:  Artemísia L Mourão; Fabiana G de Abreu; Marilu Fiegenbaum
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

4.  Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics.

Authors:  Akihiro Kanaya; Toshihiro Sato; Nobuo Fuse; Hiroaki Yamaguchi; Nariyasu Mano; Masanori Yamauchi
Journal:  J Anesth       Date:  2018-02-21       Impact factor: 2.078

Review 5.  Pharmacogenomic considerations for medications in the perioperative setting.

Authors:  Ellie H Jhun; Jeffrey L Apfelbaum; David M Dickerson; Sajid Shahul; Randall Knoebel; Keith Danahey; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenomics       Date:  2019-07       Impact factor: 2.638

6.  Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia.

Authors:  Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielinska; Barbara Tamowicz; Adam Mikstacki; Michal Walczak; Michal Prendecki; Jolanta Dorszewska; Agnieszka Pollak; Urszula Lechowicz; Monika Oldak; Kinga Huminska-Lisowska; Marta Molinska-Glura; Marlena Szalata; Ryszard Slomski
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

7.  Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility.

Authors:  Qi Zhong; Xiangdong Chen; Yan Zhao; Ru Liu; Shanglong Yao
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

8.  The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia.

Authors:  Adam Mikstacki; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielinska; Barbara Tamowicz; Michał Prendecki; Jolanta Dorszewska; Marta Molinska-Glura; Malgorzata Waszak; Ryszard Slomski
Journal:  J Appl Genet       Date:  2016-11-08       Impact factor: 3.240

9.  Genetic variation in the CYP2B6 gene is related to circulating 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) concentrations: an observational population-based study.

Authors:  Johanna Penell; Lars Lind; Tove Fall; Anne-Christine Syvänen; Tomas Axelsson; Per Lundmark; Andrew P Morris; Cecilia Lindgren; Anubha Mahajan; Samira Salihovic; Bert van Bavel; Erik Ingelsson; P Monica Lind
Journal:  Environ Health       Date:  2014-05-08       Impact factor: 5.984

Review 10.  Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.